Yes, and this is a common treatment pathway
75 For instance, the simultaneous blockade of NMDA receptors alongside acetylcholinesterase inhibition has demonstrated synergistic neuroprotective effects in experimental models of AD, suggesting a complementary mechanism of action that could translate into improved cognitive outcomes in patients
Delaying the onset of neuromuscular fatigue during intense exercise [8]
RELATED: Save up to 80% on weight loss drugs Weight loss Appetite suppressants and Orlistat, Cigna (2025) Diabetes glucagon-like peptide-1 agonists prior authorization policy, Cigna (2023) Appropriate use of prescription medications for diabetes and weight loss helps to ensure patient access and safety, Cigna Diabetes Mounjaro prior authorization policy, Cigna (2023) FDA approves first medication for obstructive sleep apnea, Food and Drug Administration (2024) Cigna to offer $200 Wegovy, Zepbound weight-loss benefit, Reuters (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
This product has not been evaluated or approved by the MHRA
